Feb 28, 2023
R. Brent Wisner serves as the managing partner of Wisner Baum (previously Baum Hedlund Aristei & Goldman) and heads up the firm's state and federal involvement with Zantac litigation. Brent personally oversees the firm’s pharmaceutical class action litigation, toxic-tort injuries, and consumer fraud litigation. Wisner began gaining notoriety in 2017 after serving as Co-lead Trial Counsel in litigation against GlaxoSmithKline (GSK) for the drug Paxil, yielding a $3 million verdict. A year later, Wisner began litigation against Monsanto Roundup, earning plaintiffs over $2.424 billion in damages across three plaintiff lawsuits–and earning Brent the title of youngest attorney to earn a billion-dollar settlement.
Trial Lawyer Magazine named Brent to their 2019 list of “America’s 50 Most Influential Trial Lawyers,” and National Trial Lawyers awarded him “Civil Plaintiffs Trial Lawyer of the Year.” The National Law Journal also named Brent to both 2019 lists of “America’s 50 Most Influential Trial Lawyers” and “Winning Litigators, Titans of Industry.” Law360 awarded Brent the title of “MVP of the Year” in In 2020 for Products Liability and the National Law Journal and American Law Magazine inducted him into the Verdicts Hall of Fame. In 2021, Brent was awarded “West Trailblazer” by The American Lawyer, and Mass Torts Made Perfect awarded him with the “Clarence Darrow Award.” Most recently, The Litigation Counsel of America (LCA), a trial lawyer honor society, hand-picked Brent to receive the title of Associate Fellow in 2022 for his achievements as a leader across multiple dockets and his ethical commitment to plaintiff law.
Brent currently maintains heavy involvement in Ranitidine litigation (Zantac), serving as Co-Lead Plaintiffs’ Liaison Counsel for the Ranitidine Product Cases (MDL No. 2924) and Co-Chair of the American Association for Justice’s Zantac Litigation Group. Brent remains extremely active in the legal community and regularly presents at legal conferences, such as MTMP, AAJ, HarrisMartin and CAALA on Zantac litigation.
Brent Social Media
LinkedIn - https://www.linkedin.com/in/r-brent-wisner-94046458/
Bio - https://www.wisnerbaum.com/attorneys/r-brent-wisner/
Wisner Baum Social Media
LinkedIn - https://www.linkedin.com/company/wisnerbaum/
Facebook - https://www.facebook.com/BaumHedlund
Twitter - https://twitter.com/WisnerBaum
Remember to subscribe and follow us on social media…
LinkedIn: https://www.linkedin.com/company/mass-tort-news